Short‐Term, Weight‐Adjusted Colchicine to Prevent Post‐CABG Arrhythmias: A Randomized, Double‐Blind, Controlled Trial
Pacing and Clinical Electrophysiology · 2026
DOI: 10.1111/pace.70278 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pacing and Clinical Electrophysiology, 2026. Verfasst von Amir Hassan Farzaneh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. Hauptthemen laut MEDLINE: Colchicine, Coronary Artery Bypass, Postoperative Complications, Arrhythmias, Cardiac. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Postoperative arrhythmias are common after coronary artery bypass graft (CABG) surgery and are linked to adverse outcomes. Colchicine, an anti‐inflammatory agent, has shown inconsistent results in prior studies, possibly due to dosing and timing variations.
Objectives
To evaluate the efficacy and safety of short‐term, weight‐adjusted colchicine initiated preoperatively for preventing postoperative arrhythmias after CABG.
Methods
In this randomized, double‐blind, placebo‐controlled trial, 172 adults scheduled for on‐pump CABG received colchicine or placebo. The regimen included a preoperative loading dose (1 mg twice daily) followed by a weight‐based maintenance dose (0.5 mg daily if 48 h) POAF, other arrhythmias, inflammatory markers (CRP, ESR), length of stay, and adverse events.
Results
Of 163 analyzed patients (81 colchicine, 82 placebo), POAF incidence was significantly lower in the colchicine group (17.3% vs. 46.3%; RR 0.37, 95% CI 0.21–0.66; p < 0.001), with an absolute risk reduction of 29.0% and number needed to treat (NNT) of 4. Colchicine reduced both early and late POAF ( p < 0.001 and p = 0.002). No significant reduction was seen in other arrhythmias. Gastrointestinal events, primarily diarrhea, were more common with colchicine (25.9% vs. 8.5%, p = 0.003), but were manageable and without serious adverse events.
Conclusion
Short‐term perioperative weight‐adjusted colchicine is effective and safe for preventing POAF after CABG, with a low NNT and manageable side effects, though it did not significantly affect other arrhythmias. Trial Registration Iranian Registry of Clinical Trials, IRCT20200328046886N6
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Cardiac Surgery, Fatemeh Zahra Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
- Education Development Center, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Biostatistics, Faculty of Health, Mazandaran University of Medical Sciences, Sari, Iran.
ORCID-Profile: Amir Hassan Farzaneh
Zitieren
APA
Farzaneh, A. H., Abbaspour, H., Habibi, V., Sadraei, S. J., Darayi, M., Moradi, S., & Nataj, A. H. (2026). Short‐Term, Weight‐Adjusted Colchicine to Prevent Post‐CABG Arrhythmias: A Randomized, Double‐Blind, Controlled Trial. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70278
Vancouver
Farzaneh AH, Abbaspour H, Habibi V, Sadraei SJ, Darayi M, Moradi S, et al. Short‐Term, Weight‐Adjusted Colchicine to Prevent Post‐CABG Arrhythmias: A Randomized, Double‐Blind, Controlled Trial. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70278
BibTeX
@article{Farzaneh2026,
author = {Farzaneh, Amir Hassan and Abbaspour, Hamideh and Habibi, Valiollah and Sadraei, Seyed Javad and Darayi, Masood and Moradi, Siavash and Nataj, Abolfazl Hossein},
title = {Short‐Term, Weight‐Adjusted Colchicine to Prevent Post‐CABG Arrhythmias: A Randomized, Double‐Blind, Controlled Trial},
journal = {Pacing and Clinical Electrophysiology},
year = {2026},
doi = {10.1111/pace.70278}
}
EUVIMED